Through continued exploration of IL11 mechanisms, optimization of therapeutic strategies, and incorporation of emerging technologies, IL11 may ultimately represent a breakthrough in improving prognosis for ICH patients and advancing precision therapy for CNS disorders. This evidence concerns the gene IL11 and central nervous system disorder.